TRENDING:

NCPE Recommends Conditional Access for Omeprazole
Stratipath And Roche Collaborate To Expand Access To Ai...
A. Menarini Diagnostics and Nucleix Form Strategic Part...
  • Home
  • Media
  • Company
Synopulse.com
  • News
  • Industry Trends
    • Pricing & Market Access
    • Earnings Report
    • Market Pulse
    • Speciality
      • Neurology
      • Orthopaedics
      • Oncology
      • Cardiometabolic
      • Pediatrics
    • Dealstreet
    • Litigation, Law & Policy
    • MedTech
  • Regulatory
    • FDA Updates
    • EMA Updates
    • Device Approvals
    • Global Compliance
  • Monthly Standout
    • Monthly Insight’s
    • GreenLight Report
  • Special Reports
    • Synopulse 360
    • Synopulse Insights
    • RWE Lens
    • White Paper
    • Case Study
  • Magazine
    • Pulse Prime
    • Pulse of the Month
  • Disease Spotlight
  • Summits
  • Podcasts

Select Page

NCPE Recommends Conditional Access for Omeprazole

NCPE Recommends Vabysmo, Signaling Retinal Policy Shift

J&J Launches AI in Surgery Funding via Polyphonic™ Fund

Hereditary Angioedema Drug From CSL Gains German Backing

New Reimbursement Strategy Boosts Ambulatory Pay

Today on Synopulse

Read More

NCPE Recommends Conditional Access for Omeprazole

NCPE Recommends Conditional Access for Omeprazole

NCPE recommends Omeprazole Appizped for reimbursement eligibility.

  • NCPE Recommends Vabysmo, Signaling Retinal Policy Shift

  • J&J Launches AI in Surgery Funding via Polyphonic™ Fund

  • Kymera Strikes License Agreement Deals With Sanofi, Gilead

Monthly Standout

Synopulse Weekly: Top Deals, FDA Moves & Pricing Insights

Synopulse Weekly: Top Deals, FDA Moves & Pricing Insights

Top biopharma deals, FDA approvals, and market access news from the past week.

Analytics & Insights

Sorry, No Posts Found
Sorry, no posts found.
Sorry, no posts found.
Synopulse Weekly

Synopulse Weekly: Top Deals, FDA Moves & Pricing Insights

Read Now
  • Cardiometabolic
  • Dealstreet
  • Device Approvals
  • EMA Updates
  • FDA Updates
  • Litigation, Law & Policy
  • MedTech
  • Monthly Insight's
  • Neurology
  • News
  • Oncology
  • Orthopaedics
  • Pediatrics
  • Pricing & Market Access
  • Regulatory
  • July 2025
  • June 2025
  • February 2025
  • January 2025
  • October 2024
  • September 2024

© 2025 Axowit | All Rights Reserved